Full title: Risk Assessment of Extractables and Leachables in Different Phases of Development. As the knowledge on the manufacturing process evolves during the development of a drug product or medical device, it is advised to include learning cycles into the development program to avoid existence of critical E&Ls. These learning cycles offer the opportunity to increase the knowledge on E&L associated with the product over its development time. Initially, chemical information should be collected on the materials used. First extraction studies will guide concerns, followed by simulation studies which are designed to mimic reality. At the end, the leachable study has to meet regulatory requirements and must cover real use conditions until end of product shelf-life, and these leachables need to be covered by a thorough toxicological risk assessment.

Hora

15:00 - 16:00 hs GMT+1

Organizador

BioPharma Asia Magazine
Compartir
Enviar a un amigo
Mi email *
Email destinatario *
Comentario *
Repite estos números *
Control de seguridad
Abril / 2021 1390 webinars
Lunes
Martes
Miércoles
Jueves
Viernes
Sábado
Domingo
Lun 29 de Abril de 2021
Mar 30 de Abril de 2021
Mié 31 de Abril de 2021
Jue 01 de Abril de 2021
Vie 02 de Abril de 2021
Sáb 03 de Abril de 2021
Dom 04 de Abril de 2021
Lun 05 de Abril de 2021
Mar 06 de Abril de 2021
Mié 07 de Abril de 2021
Jue 08 de Abril de 2021
Vie 09 de Abril de 2021
Sáb 10 de Abril de 2021
Dom 11 de Abril de 2021
Lun 12 de Abril de 2021
Mar 13 de Abril de 2021
Mié 14 de Abril de 2021